Clinical trial
Novel Non-invasive Therapy to Drive Robust and Sustained Peripheral Nerve Regeneration
NCT05848778 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Non-invasive Therapy to Drive Robust and Sustained Peripheral Nerve Regeneration
- Lead sponsor
- University of Alberta
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2025
- Completion date
- August 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.